Outcome of new-onset dysphonia in COVID-19 patients in a single tertiary centre; Wyniki leczenia nowo rozpoznanej dysfonii u pacjentów z COVID-19 w jednym ośrodku o trzecim poziomie referencyjności
Introduction: Ever since coronavirus disease 2019 (COVID-19) was first identified in December 2019, it has infected millions of people and resulted in more than 6.86 million deaths worldwide. Numerous novel manifestations have emerged ensuing COVID-19 and even though a full 2-year period has passed,...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
Medical Communications
2022
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/44132/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Introduction: Ever since coronavirus disease 2019 (COVID-19) was first identified in December 2019, it has infected millions of people and resulted in more than 6.86 million deaths worldwide. Numerous novel manifestations have emerged ensuing COVID-19 and even though a full 2-year period has passed, the ongoing pandemic remains a conundrum, especially to the healthcare system. Dysphonia, or a disorder of the voice, is among the novel manifestations that have emerged. Aim of the study: To outline the outcome of new-onset dysphonia presentation in COVID-19 patients in a single tertiary centre. Case study: We aim to discuss the clinical presentation and outcome of the 3 cases that we managed in our centre to help understand the course and outcome of new-onset dysphonia among COVID-19 patients. Result and discussion: We found that despite its viral origin, dysphonia in COVID-19 patients persisted for longer compared to other viral-induced dysphonia. New-onset dysphonia is a possible silent manifestation of COVID-19. © 2022 Hawari et al. |
|---|